Principal Investigators of their trial sites are well experienced
to administer the intravitreal drug. (Copy enclosed) and not stated any word about the co investigator
trial a Phase-III safety
and efficacy study of Vitreosolve ® for ophthalmic intravitreal injection for
inducting posterior vitreous detachment in retinopathy subjects along with
enclosure